Flamel Technologies S.A. (FLML) 16.83 $FLML
Flamel Technologies Has Returned 18.4% Since SmarTrend Recommendation (FLML)
Comtex SmarTrend(R) - Wed Dec 10, 9:23AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 25th, 2014 at $14.23. In approximately 2 weeks, Flamel Technologies has returned 18.43% as of today's recent price of $16.85.
FLML: 16.83 (+0.28)
Why Flamel Technologies (FLML) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 7:39AM CST
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on Flamel Technologies’ earnings for the coming quarter and year.
FLML: 16.83 (+0.28)
Flamel clears resistance
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 2:51PM CST
FLML: 16.83 (+0.28)
Flamel Technologies (FLML) in Focus: Stock Rises 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 7:37AM CST
Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise more than 8% on the day.
LCI: 43.58 (-0.46), FLML: 16.83 (+0.28), SCMP: 13.93 (-0.13), IG: 8.78 (+0.12)
Flamel Technologies Closes Sale of Development and Manufacturing Facility in Pessac, France to Recipharm AB
Marketwired - Mon Dec 01, 3:15PM CST
Flamel Technologies (NASDAQ: FLML) announced today that it has closed the sale of its development and manufacturing facility located in Pessac, France, to Recipharm AB that was announced on November 28, 2014. Under the agreement, Recipharm paid Flamel EUR 10.6 million and made an investment of EUR 10.5 million in Flamel's stock at a purchase price equal to the trailing 20-day average price.
FLML: 16.83 (+0.28)
Flamel Technologies plans divestiture of the Pessac facility
M2 - Mon Dec 01, 7:37AM CST
Flamel Technologies (NASDAQ:FLML) reported on Friday an agreement to sell its development and manufacturing facility located in Pessac, France for a purchase price of EUR10.6m before year end 2014.
FLML: 16.83 (+0.28)
3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Nov 29, 1:01PM CST
The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called "patent cliff."...
JNJ: 104.43 (-2.29), FLML: 16.83 (+0.28), GERN: 3.24 (+0.01), ICPT: 137.69 (-2.48), IBB: 306.10 (-3.95)
Flamel sells development & manufacturing facility to Swedish firm
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:49AM CST
FLML: 16.83 (+0.28), GSK: 42.42 (-0.93)
Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB
Marketwired - Fri Nov 28, 7:15AM CST
Flamel Technologies (NASDAQ: FLML) announced today that it has entered into an agreement to divest its development and manufacturing facility located in Pessac, France, to Recipharm AB. Under the agreement, Recipharm will pay Flamel EUR 10.6 million and make an investment of EUR 10.5 million in Flamel's stock upon the closing of deal at a purchase price equal to the trailing 20-day average price. This new partnership allows Flamel to retain access to the development and manufacturing capabilities of Pessac and gain the use of any of Recipharm's other facilities for the development or manufacture of their proprietary pipeline if needed. The Pessac facility is not currently used for the production of Flamel finished products and Flamel intends to continue to outsource to third party contract manufacturing companies like Recipharm.
FLML: 16.83 (+0.28)
Recipharm acquires Flamel Technologies facility in Pessac, France
M2 - Fri Nov 28, 4:36AM CST
Recipharm AB (STO: RECI), a CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry, announced on Thursday the signing of an agreement with Flamel Technologies SA (Nasdaq:FLML), a drug delivery company, under which Recipharm will purchase Flamel's development and manufacturing facility located in Pessac, France.
FLML: 16.83 (+0.28)
Flamel Technologies: A Turnaround Story With Lots Of Upside
Small Pharma Analyst - at Seeking Alpha - Fri Nov 21, 12:05PM CST
FLML: 16.83 (+0.28), CNCE: 11.22 (+0.03)
Comparing 3 Major Drug Delivery Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 17, 10:57AM CST
FLML: 16.83 (+0.28), PETS: 13.52 (-0.01), ALKS: 54.41 (-1.22)
Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 43.58 (-0.46), FLML: 16.83 (+0.28), ADHD: 3.41 (+0.16), SCMP: 13.93 (-0.13)
Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 13.78 (-0.11), IMDZ: 22.35 (-0.20), OLED: 26.61 (-0.25), FUEL: 14.85 (+0.89), CZR: 12.83 (-2.03), NTIC: 21.00 (-0.41), RESN: 9.01 (-0.10), OREX: 5.74 (-0.02), VBFC: 22.76 (+0.01), FLML: 16.83 (+0.28), ACHN: 13.28 (-0.11), RDI: 12.59 (unch), AMOT: 20.77 (-1.16), SUSQ: 13.06 (-0.19), RDIB: 12.88 (+0.52)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 11:48AM CST
IMDZ: 22.35 (-0.20), VTNR: 3.21 (-0.03), CYBR: 37.98 (+0.13), LJPC: 13.81 (+0.76), ZAZA: 1.46 (-0.13), XPLR: 6.30 (-0.10), FUEL: 14.85 (+0.89), NADL: 1.47 (-0.09), DWA: 21.75 (+0.04), CZR: 12.83 (-2.03), RCAP: 11.81 (-0.10), AMTX: 4.33 (+0.04), FLML: 16.83 (+0.28), AMOT: 20.77 (-1.16), RVNC: 17.45 (-0.23), LOCM: 1.18 (-0.08), JGW: 8.68 (-0.32), ICLD: 3.01 (-0.05), VPCO: 1.31 (+0.04), CSH: 21.11 (+0.04)
Flamel Technologies (FLML) Crumbles: Stock Falls by 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:38AM CST
Flamel Technologies (FLML) fell over 7% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down nearly 15% in the past one-month time frame.
FLML: 16.83 (+0.28), AUXL: 33.11 (-0.72), IG: 8.78 (+0.12), BIOD: 1.38 (-0.03)
Flamel Technologies' Q3 fiscal 2014 net loss widens to USD10.0m
M2 - Mon Nov 03, 5:44AM CST
Drug delivery company Flamel Technologies (NASDAQ:FLML) disclosed on Friday its net loss of USD10.0m for the third quarter of fiscal year 2014.
FLML: 16.83 (+0.28)
Flamel Technologies SA's (FLML) CEO Michael Anderson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 3:20PM CDT
FLML: 16.83 (+0.28)
More on Flamel Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 10:48AM CDT
FLML: 16.83 (+0.28)
Flamel Technologies Has Returned 18.4% Since SmarTrend Recommendation (FLML)
Comtex SmarTrend(R) - Wed Dec 10, 9:23AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 25th, 2014 at $14.23. In approximately 2 weeks, Flamel Technologies has returned 18.43% as of today's recent price of $16.85.
FLML: 16.83 (+0.28)
Why Flamel Technologies (FLML) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 7:39AM CST
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on Flamel Technologies’ earnings for the coming quarter and year.
FLML: 16.83 (+0.28)
Flamel clears resistance
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 2:51PM CST
FLML: 16.83 (+0.28)
Flamel Technologies (FLML) in Focus: Stock Rises 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 7:37AM CST
Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise more than 8% on the day.
LCI: 43.58 (-0.46), FLML: 16.83 (+0.28), SCMP: 13.93 (-0.13), IG: 8.78 (+0.12)
Flamel Technologies Closes Sale of Development and Manufacturing Facility in Pessac, France to Recipharm AB
Marketwired - Mon Dec 01, 3:15PM CST
Flamel Technologies (NASDAQ: FLML) announced today that it has closed the sale of its development and manufacturing facility located in Pessac, France, to Recipharm AB that was announced on November 28, 2014. Under the agreement, Recipharm paid Flamel EUR 10.6 million and made an investment of EUR 10.5 million in Flamel's stock at a purchase price equal to the trailing 20-day average price.
FLML: 16.83 (+0.28)
Flamel Technologies plans divestiture of the Pessac facility
M2 - Mon Dec 01, 7:37AM CST
Flamel Technologies (NASDAQ:FLML) reported on Friday an agreement to sell its development and manufacturing facility located in Pessac, France for a purchase price of EUR10.6m before year end 2014.
FLML: 16.83 (+0.28)
3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Nov 29, 1:01PM CST
The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called "patent cliff."...
JNJ: 104.43 (-2.29), FLML: 16.83 (+0.28), GERN: 3.24 (+0.01), ICPT: 137.69 (-2.48), IBB: 306.10 (-3.95)
Flamel sells development & manufacturing facility to Swedish firm
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:49AM CST
FLML: 16.83 (+0.28), GSK: 42.42 (-0.93)
Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB
Marketwired - Fri Nov 28, 7:15AM CST
Flamel Technologies (NASDAQ: FLML) announced today that it has entered into an agreement to divest its development and manufacturing facility located in Pessac, France, to Recipharm AB. Under the agreement, Recipharm will pay Flamel EUR 10.6 million and make an investment of EUR 10.5 million in Flamel's stock upon the closing of deal at a purchase price equal to the trailing 20-day average price. This new partnership allows Flamel to retain access to the development and manufacturing capabilities of Pessac and gain the use of any of Recipharm's other facilities for the development or manufacture of their proprietary pipeline if needed. The Pessac facility is not currently used for the production of Flamel finished products and Flamel intends to continue to outsource to third party contract manufacturing companies like Recipharm.
FLML: 16.83 (+0.28)
Recipharm acquires Flamel Technologies facility in Pessac, France
M2 - Fri Nov 28, 4:36AM CST
Recipharm AB (STO: RECI), a CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry, announced on Thursday the signing of an agreement with Flamel Technologies SA (Nasdaq:FLML), a drug delivery company, under which Recipharm will purchase Flamel's development and manufacturing facility located in Pessac, France.
FLML: 16.83 (+0.28)
Flamel Technologies: A Turnaround Story With Lots Of Upside
Small Pharma Analyst - at Seeking Alpha - Fri Nov 21, 12:05PM CST
FLML: 16.83 (+0.28), CNCE: 11.22 (+0.03)
Comparing 3 Major Drug Delivery Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 17, 10:57AM CST
FLML: 16.83 (+0.28), PETS: 13.52 (-0.01), ALKS: 54.41 (-1.22)
Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 43.58 (-0.46), FLML: 16.83 (+0.28), ADHD: 3.41 (+0.16), SCMP: 13.93 (-0.13)
Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 13.78 (-0.11), IMDZ: 22.35 (-0.20), OLED: 26.61 (-0.25), FUEL: 14.85 (+0.89), CZR: 12.83 (-2.03), NTIC: 21.00 (-0.41), RESN: 9.01 (-0.10), OREX: 5.74 (-0.02), VBFC: 22.76 (+0.01), FLML: 16.83 (+0.28), ACHN: 13.28 (-0.11), RDI: 12.59 (unch), AMOT: 20.77 (-1.16), SUSQ: 13.06 (-0.19), RDIB: 12.88 (+0.52)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 11:48AM CST
IMDZ: 22.35 (-0.20), VTNR: 3.21 (-0.03), CYBR: 37.98 (+0.13), LJPC: 13.81 (+0.76), ZAZA: 1.46 (-0.13), XPLR: 6.30 (-0.10), FUEL: 14.85 (+0.89), NADL: 1.47 (-0.09), DWA: 21.75 (+0.04), CZR: 12.83 (-2.03), RCAP: 11.81 (-0.10), AMTX: 4.33 (+0.04), FLML: 16.83 (+0.28), AMOT: 20.77 (-1.16), RVNC: 17.45 (-0.23), LOCM: 1.18 (-0.08), JGW: 8.68 (-0.32), ICLD: 3.01 (-0.05), VPCO: 1.31 (+0.04), CSH: 21.11 (+0.04)
Flamel Technologies (FLML) Crumbles: Stock Falls by 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:38AM CST
Flamel Technologies (FLML) fell over 7% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down nearly 15% in the past one-month time frame.
FLML: 16.83 (+0.28), AUXL: 33.11 (-0.72), IG: 8.78 (+0.12), BIOD: 1.38 (-0.03)
Flamel Technologies' Q3 fiscal 2014 net loss widens to USD10.0m
M2 - Mon Nov 03, 5:44AM CST
Drug delivery company Flamel Technologies (NASDAQ:FLML) disclosed on Friday its net loss of USD10.0m for the third quarter of fiscal year 2014.
FLML: 16.83 (+0.28)
Flamel Technologies SA's (FLML) CEO Michael Anderson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 3:20PM CDT
FLML: 16.83 (+0.28)
More on Flamel Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 10:48AM CDT
FLML: 16.83 (+0.28)
